[HTML] cell.com

[HTML][HTML] R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway

Y Gao, X Ouyang, L Zuo, Y Xiao, Y Sun… - Molecular Therapy …, 2021 - cell.com
Isocitrate dehydrogenase (IDH) mutations increase (R)-2-hydroxyglutarate (R-2HG)
production; however, functional mechanisms of R-2HG in regulating cholangiocarcinoma …
被引用次数：15 相关文章
[HTML] sciencedirect.com

[HTML][HTML] R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway

Y Gao, X Ouyang, L Zuo, Y Xiao, Y Sun… - Molecular Therapy …, 2021 - Elsevier
Isocitrate dehydrogenase (IDH) mutations increase (R)-2-hydroxyglutarate (R-2HG)
production; however, functional mechanisms of R-2HG in regulating cholangiocarcinoma …

R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway

Y Gao, X Ouyang, L Zuo, Y Xiao… - Molecular therapy …, 2021 - pubmed.ncbi.nlm.nih.gov
Isocitrate dehydrogenase (IDH) mutations increase (R)-2-hydroxyglutarate (R-2HG)
production; however, functional mechanisms of R-2HG in regulating cholangiocarcinoma …
[HTML] nih.gov

[HTML][HTML] R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway

Y Gao, X Ouyang, L Zuo, Y Xiao, Y Sun… - Molecular Therapy …, 2021 - ncbi.nlm.nih.gov
Isocitrate dehydrogenase (IDH) mutations increase (R)-2-hydroxyglutarate (R-2HG)
production; however, functional mechanisms of R-2HG in regulating cholangiocarcinoma …

R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway.

Y Gao, X Ouyang, L Zuo, Y Xiao, Y Sun… - Molecular Therapy …, 2021 - europepmc.org
Isocitrate dehydrogenase (IDH) mutations increase (R)-2-hydroxyglutarate (R-2HG)
production; however, functional mechanisms of R-2HG in regulating cholangiocarcinoma …

R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway.

Y Gao, X Ouyang, L Zuo, Y Xiao, Y Sun… - Molecular Therapy …, 2021 - europepmc.org
Isocitrate dehydrogenase (IDH) mutations increase (R)-2-hydroxyglutarate (R-2HG)
production; however, functional mechanisms of R-2HG in regulating cholangiocarcinoma …